🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for transformative findings that illuminate how the body's defense network targets dangerous infections while sparing the body's own cells.

A trio of esteemed researchers—Japan's Prof. Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—share this accolade.

The research identified unique "security guards" within the immune system that eliminate rogue defense cells that could attacking the body.

These findings are now paving the way for innovative treatments for immune disorders and cancer.

The winners will share a monetary award worth 11 million SEK.

Decisive Findings

"Their work has been decisive for comprehending how the immune system operates and why we don't all develop severe self-attack conditions," commented the chair of the award panel.

This team's studies explain a core mystery: In what way does the immune system defend us from countless invaders while keeping our own tissues unharmed?

The immune system employs white blood cells that search for signs of disease, including pathogens and germs it has not met before.

Such defenders employ detectors—known as recognition units—that are produced by chance in a vast number of combinations.

This provides the immune system the capacity to combat a broad range of threats, but the unpredictability of the process unavoidably produces white blood cells that may attack the host.

Security Guards of the Immune System

Researchers previously knew that some of these harmful white blood cells were destroyed in the thymus—where white blood cells mature.

This year's award recognizes the identification of T-reg cells—described as the immune system's "peacekeepers"—which patrol the body to disarm other immune cells that attack the healthy cells.

It is known that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel stated, "These findings have laid the foundation for a new field of research and spurred the development of new treatments, for instance for tumors and immune disorders."

In malignancies, regulatory T-cells block the body from fighting the tumor, so studies are focused on reducing their quantity.

In self-attack disorders, trials are exploring boosting T-reg cells so the body is not being harmed. A similar method could also be effective in reducing the risks of transplanted organ rejection.

Pioneering Experiments

Prof Sakaguchi, from a Japanese institution, conducted experiments on rodents that had their thymus extracted, leading to self-attack conditions.

The researcher demonstrated that introducing immune cells from other mice could stop the illness—implying there was a system for preventing defenders from attacking the body.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at a biotech firm in San Francisco, were investigating an inherited immune disorder in mice and humans that led to the discovery of a gene critical for the way T-regs function.

"The groundbreaking research has uncovered how the immune system is controlled by T-reg cells, preventing it from accidentally targeting the healthy cells," said a prominent physiology specialist.

"This research is a remarkable illustration of how fundamental physiological study can have broad consequences for human health."